Gaudi Clinical Co., Ltd.
Basic information
- Head office
- 10F, Neo Kawai Building, 4-8-15 Nihonbashi-Honcho, Chuo-ku, Tokyo
- Chief executive
- Morikuni Hida
- Capital
- 100,000,000
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 2021-06-10
- End date
Websites
Business
Related companies
—
Network
News
Gaudi Clinical Presents Latest Dental Regenerative Medicine at Implant Dentistry Congress
Gaudi Clinical Co., Ltd. participated in the 56th annual meeting of the Japanese Society of Oral Implantology, holding a seminar and exhibition on integrating dental implants with stem cell therapy. It presented information on regenerative medicine safety and clinical applications and outlined support for implementing stem cells and PRP in implant treatment.
Gaudi Clinical’s Regenerative Medicine Infrastructure Featured on Nature’s Website
Gaudi Clinical Inc.’s work was featured on the website of the international scientific journal Nature. The article introduces the company’s platform and technologies for implementing regenerative medicine in practice and expanding it globally.
Gaudi Clinical to Present Regenerative Medicine at Japanese Society of Oral Implantology Meeting
Gaudi Clinical Inc. will participate in the 56th Annual Meeting of the Japanese Society of Oral Implantology and present its efforts and services for putting dental regenerative medicine into practice. It will co-host a seminar and exhibit during the meeting.
Gaudi Clinical and Tiger Corporation Develop Cell Transport Container
Gaudi Clinical Inc. and Tiger Corporation jointly developed the Vacuum-Insulated Cell Pod, a compact vacuum-insulated container designed to support cell transport for regenerative medicine. They plan to begin demonstration testing in 2026 and continue improvements toward practical use in 2027.
Gaudi Clinical Begins Cell Transport via the Tokaido Shinkansen
In cooperation with Central Japan Railway Company and JR Tokai Logistics, Gaudi Clinical Inc. will launch a service for transporting cells for regenerative medicine via the Tokaido Shinkansen on August 17, 2026. This will expand the areas supplied with regenerative medicine to Nagoya and Osaka.
Gaudi Clinical's Compact Clean Booth “KiOSK” Selected for Support Program
Gaudi Clinical Inc.'s stationary, pressure-adjustable compact clean booth, KiOSK, has been selected for a support program run by the Tokyo Metropolitan Small and Medium Enterprise Support Center. The company aims to advance an infrastructure revolution in regenerative medicine and expand sales channels to medical institutions and biotechnology companies.
Gaudi Clinical Presents Latest Solutions in Hyogo
Gaudi Clinical Inc. participated in the 39th Annual Meeting of the Japanese Orthopaedic Association of Clinical Physicians, co-hosting a seminar and exhibiting. The seminar discussed effective use of PRP therapy and implementation strategies. The exhibition introduced the company’s support for adopting regenerative medicine.